Lance Bass Shares his Journey with Diabetes Including his Misdiagnosis of Type 2 Diabetes: How Continuous Glucose Monitoring Helped Lance Bass Take Control of his Health

Lance Bass discusses an honest look at misdiagnosis, diabetes stigma, and how real-time Continuous Glucose Monitoring (CGM) transformed his life on this special episode of Real-Time Real Talk recorded live at the American Diabetes Association conference (ADA) in Chicago this June. When Lance was first diagnosed with type 2 diabetes, it didn’t make sense - he ate well, exercised, and didn’t fit the typical profile. But as his glucose remained high and symptoms worsened, he discovered he actually had LADA (Latent Autoimmune Diabetes in Adults), a slow-progressing form of type 1 diabetes. Host Cher Pastore, MS, RD, CDCES, BC-ADM sits down with Lance to unpack his journey from misdiagnosis to managing his condition with CGM and advanced diabetes technology. Lance shares how CGM with the Dexcom G7 transformed his diabetes management, allowing him to see blood sugar levels in real time, avoid dangerous lows, and personalize his food and insulin decisions. They discuss everything from automated insulin delivery systems to blood sugar monitoring tips, glucose sensors, and the mental relief that comes from not having to guess what’s happening in your body. He also opens up about raising awareness, reducing stigma for young people with diabetes, and why showing his G7 publicly has helped others feel seen and supported. Whether you're a healthcare provider, parent, or person living with diabetes, this episode offers powerful insight into the life-changing potential of CGM technology and is a must-listen for anyone affected by type 1 diabetes, type 2 diabetes, or prediabetes - including patients, endocrinologists, and primary care providers. The interview offers an honest and insightful look at how biosensor tools like CGM are reshaping diabetes treatment, diabetes education, and metabolic health outcomes.